CDP CARDURION PHARMA
Live / Registered — Registered (as of 20 Jan 2026)
What this means for you
Registered since 20 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99199719
- Registration number
- 8107929
- Mark type
- Design + words
- Filed
- 23 May 2025
- Published for opposition
- 02 Dec 2025
- Registered
- 20 Jan 2026
- Attorney of record
- Valerie Brennan
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical field; conducting clinical trials for others in the field of cardiovascular medicine
Owner
- Cardurion Pharmaceuticals, Inc., Burlington, MA, US
- Cardurion Pharmaceuticals, Inc., Burlington, MA, US
- Cardurion Pharmaceuticals, Inc., Burlington, MA, US
Prior registrations
Prosecution history
- 20 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 02 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Dec 2025 — PUBLISHED FOR OPPOSITION
- 26 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Nov 2025 — ASSIGNED TO EXAMINER
- 09 Oct 2025 — ASSIGNED TO EXAMINER
- 30 Sept 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 30 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 May 2025 — APPLICATION FILING RECEIPT MAILED
- 23 May 2025 — NEW APPLICATION ENTERED